CAS 303-98-0 Ubidecarenone Coenzyme Q10 Stay Caducity Bulk Drug Crystalline Powder CAS NO.303-98-0

CAS 303-98-0 Ubidecarenone Coenzyme Q10 Stay Caducity Bulk Drug Crystalline Powder

 

Quick detail

---

Synonyms: LABOTEST-BB LT00244787;COQ10;COENZYME Q10;Q-10;Q10 COENZYME;UBIDECARENONE;UBIQUINONE;UBIQUINONE-10
CAS: 303-98-0
MF: C59H90O4
MW: 863.34
EINECS: 206-147-9

Chemical Properties Yellow-Orange Crystalline Powder

****Usage antioxidant, cardiovascular agent
****Usage Antibacterial and antioxidant for preventing and treating cancer.
****Usage Antibacterial, antioxidant
****Biological Activity Component of the mitochondrial transporter chain that behaves as a powerful antioxidant. Displays neuroprotective activity.

 

Q10 Description

---

1. It can reduce myocardial contractility decrease , reduce creatine phosphate and ATP content decrease in acute ischemia, maintaining morphology of ischemic myocardium mitochondria, having a protective effect for myocardial ischemia.
2. It can increase cardiac output, reduced peripheral resistance, conducive to anti-heart failure treatment, may inhibit the synthesis and secretion of aldosterone, and block its effects on the kidney tubules.
3. Under hypoxic conditions in vitro perfusion animals ventricular muscle, it can shorten the duration of the action potential, resulting in ventricular arrhythmia threshold than the control animals.
4. It can decrease peripheral vascular resistance, and owns anti-aldosterone effect.
5. Ubidecarenone owns anti-cardiotoxic effects and hepatoprotective effect of doxorubicin.

 

Ubidecarenone Benefits:

---

1	Anti-Aging As a strong antioxidant Q10 protects cells from chemicals and other harmful factors.
2	Anti-oxidant Q10 naturally prevents our body and cells from free radicals damage and works as a shield against harmful effects.
3	Muscles are also in need of this enzyme, due to its energy boosting quality. Experiments proved that people who had a balanced Q10 level were more energetic and vigorous
4	Heart-related problems It is proven helpful in treating heart-related problems such as congestive heart failure and to lower high blood pressure.
5	Improves immunity and can dramatically slow tumor growth.

 

Q10 Indications

---

1. the treatment of heart failure and dilated cardiomyopathy: Ubidecarenone has excellent repair effect on myocardial ischemia (hypoxia) defects caused by heart disease, and can significantly improve cardiac hypertrophy and dilated cardiomyopathy.

2. blood pressure lowering,and lipid-lowering effects: a 12-week double-blind test for 46 men and 37 female with high blood pressure found that patients whose daily consumption of 120 mg (twice) , blood pressure dropped by an average of about 17 mm Hg.

3. the antioxidant activity, application in the cardiovascular system: prevention of atherosclerosis, myocardial infarction and thrombosis, as a strong antioxidant, Ubidecarenone can resist the oxidation of LDL in the blood, reduce the formation of atherosclerosis, prevent myocardial infarction and thrombosis.

4. the treatment of congestive heart weakness: In 1970, the scientist Folkers shown that compared with the conventional drugs, daily consumption of 100 mg of Ubidecarenone for two consecutive months ,significantly improved 2/3 patient's heart function in clinical trials.

5. for post-surgical treatment of heart disease: compared with the patients who had not used Ubidecarenone, the recovery time of patients eating Ubidecarenone is greatly reduced.

6. delaying the development of heart failure, reduce mortality: Ubidecarenone can treat chest pain caused by the narrowing of coronary arteries, enhance heart beating capacity and hypoxia tolerance.

7. anti-aging and beauty: Ubidecarenone can help the skin to prevent oxidative damage to DNA, and anti-light aging, reduce wrinkles. Ubidecarenone are also commonly used in a variety of anti-wrinkle, firming and skin repair formulations.

8. anti-fatigue: Ubidecarenone can protect and restore the integrity of the biofilm structure, it plays the membrane potential stabilizing role.